Illumina (NASDAQ:ILMN) stated loss of 172,736 shares or 2.5% in the short interest. The short interest registered from 7,064,707 on May 31,2016 to 6,891,971 on June 15,2016. In terms of floated shares, the shorted positions stood at 4.7%. The stock has been averaging 835,589 shares daily in trading and would need 8 days to cover the shorts. The information was released by Financial Industry Regulatory Authority, Inc (FINRA) on June 24th after market close.
Illumina (NASDAQ:ILMN): The stock opened at $139.50 on Friday but the bulls could not build on the opening and the stock topped out at $143.19 for the day. The stock traded down to $138.36 during the day, due to lack of any buying support eventually closed down at $138.91 with a loss of -5.24% for the day. The stock had closed at $146.59 on the previous day. The total traded volume was 5,102,420 shares.
The company shares have dropped -35.08% from its 1 Year high price. On Jul 20, 2015, the shares registered one year high at $242.37 and the one year low was seen on May 4, 2016. The 50-Day Moving Average price is $141.40 and the 200 Day Moving Average price is recorded at $155.99.
Stocks of Illumina (NASDAQ:ILMN) rallied by 1.36% during the past week but lost 3.43% on a 4-week basis. The company has outperformed the S&P 500 by 3.04% in the past week but underperformed the index by 0.51% in the last 4 weeks.
Illumina, Inc. is engaged in production development of sequencing-and array-based solutions for genetic analysis. The Company offers integrated systems, consumables and analysis tools for genetic analysis. It also manufactures sequencing and array platforms, reagent kits and scanning equipment. Its customers include genomic research centers, academic institutions, government laboratories, hospitals and reference laboratories, pharmaceutical, biotechnology, agrigenomics, commercial molecular diagnostic and consumer genomics companies. Its sequencing instruments perform a range of nucleic-acid analyses across a range of sample sizes. Its products and services are used for basic analysis and research, including de novo sequencing, genetic variation analysis, epigenetics and targeted screening, among others. It also provides products and services for other life sciences applied markets, such as agrigenomics. It also offers Clarity Run Manager, Clarity LIMS Silver and Clarity LIMS Gold.